Stefanie Schüpke

4.3k total citations · 1 hit paper
40 papers, 788 citations indexed

About

Stefanie Schüpke is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Stefanie Schüpke has authored 40 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 24 papers in Surgery and 8 papers in Internal Medicine. Recurrent topics in Stefanie Schüpke's work include Antiplatelet Therapy and Cardiovascular Diseases (21 papers), Coronary Interventions and Diagnostics (18 papers) and Acute Myocardial Infarction Research (14 papers). Stefanie Schüpke is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (21 papers), Coronary Interventions and Diagnostics (18 papers) and Acute Myocardial Infarction Research (14 papers). Stefanie Schüpke collaborates with scholars based in Germany, United States and Italy. Stefanie Schüpke's co-authors include Adnan Kastrati, Heribert Schunkert, Karl‐Ludwig Laugwitz, Robert A. Byrne, Massimiliano Fusaro, Petra Hoppmann, Julinda Mehilli, Steffen Maßberg, Tareq Ibrahim and Nikolaus Sarafoff and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Stefanie Schüpke

37 papers receiving 773 citations

Hit Papers

Duration of Triple Therapy in Patients Requiring Oral Ant... 2015 2026 2018 2022 2015 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Schüpke Germany 14 615 321 186 106 103 40 788
Samuel Rodriguez United States 7 205 0.3× 219 0.7× 46 0.2× 51 0.5× 34 0.3× 11 413
Steven Eisenberg United States 9 142 0.2× 179 0.6× 83 0.4× 115 1.1× 57 0.6× 13 393
Clare Appleby United Kingdom 10 499 0.8× 284 0.9× 170 0.9× 103 1.0× 84 0.8× 32 642
Francis Cajfinger France 9 342 0.6× 138 0.4× 519 2.8× 84 0.8× 15 0.1× 17 652
Miguel Ángel Santos Spain 10 183 0.3× 163 0.5× 72 0.4× 49 0.5× 20 0.2× 21 395
Mats Hedberg Sweden 9 129 0.2× 199 0.6× 193 1.0× 91 0.9× 7 0.1× 18 381
Gabriella Mezzena Italy 7 366 0.6× 92 0.3× 30 0.2× 26 0.2× 113 1.1× 10 426
Philip Wells Canada 10 172 0.3× 177 0.6× 353 1.9× 26 0.2× 12 0.1× 16 407
Marc Durian Netherlands 7 135 0.2× 69 0.2× 201 1.1× 49 0.5× 22 0.2× 13 419
Ralph George United States 4 389 0.6× 298 0.9× 495 2.7× 42 0.4× 8 0.1× 5 641

Countries citing papers authored by Stefanie Schüpke

Since Specialization
Citations

This map shows the geographic impact of Stefanie Schüpke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Schüpke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Schüpke more than expected).

Fields of papers citing papers by Stefanie Schüpke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Schüpke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Schüpke. The network helps show where Stefanie Schüpke may publish in the future.

Co-authorship network of co-authors of Stefanie Schüpke

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Schüpke. A scholar is included among the top collaborators of Stefanie Schüpke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Schüpke. Stefanie Schüpke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kirchner, Marietta, Stefanie Schüpke, & Meinhard Kieser. (2024). Optimal sample size allocation for two‐arm superiority and non‐inferiority trials with binary endpoints. Pharmaceutical Statistics. 23(5). 678–686.
2.
Adler, Kristin, Katharina Mayer, Isabell Bernlochner, et al.. (2023). Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention. Thrombosis and Haemostasis. 124(4). 297–306. 4 indexed citations
3.
Bikdeli, Behnood, David Erlinge, Marco Valgimigli, et al.. (2023). Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials. Circulation. 148(16). 1207–1219. 15 indexed citations
4.
5.
Bongiovanni, Dario, Katharina Mayer, Dominick J. Angiolillo, et al.. (2022). Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy. Arteriosclerosis Thrombosis and Vascular Biology. 43(2). e83–e93. 13 indexed citations
6.
Coughlan, J J, Gjin Ndrepepa, Stefanie Schüpke, et al.. (2021). Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial. European Heart Journal Acute Cardiovascular Care. 10(10). 1117–1124. 3 indexed citations
7.
Mayer, Katharina, Senta Gewalt, Tanja Morath, et al.. (2021). Comparison of Vascular Closure Devices vs Manual Compression After Femoral Artery Puncture in Patients on Oral Anticoagulation — Post Hoc Analysis of the ISAR-CLOSURE Trial. ˜The œJournal of invasive cardiology. 33(9). E709–E715.
8.
Gewalt, Senta, Gjin Ndrepepa, Costanza Pellegrini, et al.. (2021). Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial. Journal of Atherosclerosis and Thrombosis. 29(5). 747–761. 6 indexed citations
9.
Manzo‐Silberman, Stéphane, Emanuela Piccaluga, Maria Radu, et al.. (2020). Radiation protection measures and sex distribution in European interventional catheterisation laboratories. EuroIntervention. 16(1). 80–82. 5 indexed citations
10.
Mehilli, Julinda, Moritz Baquet, Willibald Hochholzer, et al.. (2020). Randomized Comparison of Intensified and Standard P2Y 12 -Receptor-Inhibition Before Elective Percutaneous Coronary Intervention. Circulation Cardiovascular Interventions. 13(6). e008649–e008649. 22 indexed citations
11.
Harada, Yukinori, Simon Schneider, Róisín Colleran, et al.. (2019). Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated?. Revista Española de Cardiología (English Edition). 73(3). 225–231. 1 indexed citations
12.
Goedel, Alexander, K. Anette Fiedler, Julinda Mehilli, et al.. (2019). Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation. EuroIntervention. 15(8). 700–706. 3 indexed citations
13.
Sarafoff, Nikolaus, Bernhard Haller, Dirk Sibbing, et al.. (2018). Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. 92(7). 1239–1246. 1 indexed citations
14.
Colleran, Róisín, Sebastian Kufner, Julinda Mehilli, et al.. (2018). Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions. Journal of the American College of Cardiology. 71(18). 1973–1982. 25 indexed citations
15.
Chieffo, Alaide, Gill Louise Buchanan, Julinda Mehilli, et al.. (2018). Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee. EuroIntervention. 14(11). e1227–e1235. 12 indexed citations
16.
Harada, Yukinori, Katharina Mayer, Jonathan Michel, et al.. (2016). TCT-207 Extended validation of a decision tool (DAPT score) in patients randomized to 6 or 12 months dual antiplatelet therapy after percutaneous coronary intervention with predominantly second-generation drug-eluting stents. Journal of the American College of Cardiology. 68(18). B84–B85. 3 indexed citations
17.
Ndrepepa, Gjin, Raisuke Iijima, Sebastian Kufner, et al.. (2016). Association of progression or regression of coronary artery atherosclerosis with long-term prognosis. American Heart Journal. 177. 9–16. 13 indexed citations
18.
Capranzano, Piera, Vijay Kunadian, Josepa Mauri, et al.. (2016). Motivations for and barriers to choosing an interventional cardiology career path: results from the EAPCI Women Committee worldwide survey. EuroIntervention. 12(1). 53–59. 49 indexed citations
19.
Kufner, Sebastian, Salvatore Cassese, Franz–Josef Neumann, et al.. (2015). Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis. JACC: Cardiovascular Interventions. 8(7). 877–884. 78 indexed citations
20.
Fiedler, K. Anette, Michael Mæng, Julinda Mehilli, et al.. (2015). Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation. Journal of the American College of Cardiology. 65(16). 1619–1629. 287 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026